Sort
50,496 grants matching “lung cancer”
Clinically-Relevant Regulatory Networks in the Lung Tumor Microenvironment
$537,303Sylvia Katina Plevritis · Stanford University · U01 · FY2013 · CA
Mechanisms of Normal Tissue Toxicity
$537,232Deborah Citrin · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Revisiting Prior Cancer as an Exclusion Criterion for Cancer Clinical Trials
$537,213Sandi Leigh Pruitt · Ut Southwestern Medical Center · R01 · FY2019 · CA
UCLA SPORE IN LUNG CANCER
$537,211Steven M. Dubinett · University Of California Los Angeles · P50 · FY2007 · CA
Electronic cigarette derived free radicals, oxidative stress and inflammation in lung cancer development
$537,192Jay Louis Zweier · Ohio State University · R01 · FY2024 · CA
MOLECULAR EPIDEMIOLOGY OF LUNG CANCER
$537,172Chu Chen · Fred Hutchinson Cancer Research Center · R01 · FY2007 · CA
Confocal Core for the Laboratory of Cellular and Molecular Biology
$537,138Valarie Barr · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
A platform to functionally sort and analyze tumor cells within combinatorial metastatic micorenvironments
$537,134David Kevin Wood · University Of Minnesota · R01 · FY2024 · CA
The Role of Pdcd4 in Translation, Tumorigenesis and Tumor Progression
$537,100Nancy H. Colburn · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
The Role of AP-1 and Other Transcription Factors in Cancer Cause and Prevention
$537,100Nancy H. Colburn · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Mechanisms of mutant p53 reactivation
$537,081Peter Kaiser · University Of California-Irvine · R01 · FY2024 · CA
Reducing the Symptom Burden Produced by Aggressive Cancer Therapies
$537,079Charles S Cleeland · University Of Tx Md Anderson Can Ctr · R01 · FY2013 · CA
Defining the roles of mutant p53 and Mdm2 in metastasis
$537,052Carol Prives · Icahn School Of Medicine At Mount Sinai · P01 · FY2025 · CA
Proton-coupled folate/antifolate transport
$537,037Israel David Goldman · Albert Einstein College Of Medicine · R01 · FY2010 · CA
Tumor Microenvironment in Cancer Progression
$536,966Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Quantitative Volume and Density Response Assessment: Sarcoma and HCC as a Model
$536,959Lawrence H Schwartz · Columbia University Health Sciences · U01 · FY2013 · CA
Comparative functional genomics for lung cancer gene discovery
$536,945Eric Alejandro Sweet-Cordero · Stanford University · R01 · FY2011 · CA
Targeting myeloid suppression to enhance anti-tumor immunity in breast cancer
$536,866Evanthia Theodosiou Roussos Torres · University Of Southern California · R01 · FY2024 · CA
Multiparameter single-cell genomics platform for personalized treatment of cancer
$536,852Eric Brouzes · State University New York Stony Brook · R01 · FY2018 · CA
EZH2 in cancer biology and novel inhibitors
$536,827Jun Qi · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Multilevel Determinants of Racial/Ethnic Disparities in Lung Cancer Screening Utilization
$536,775Lori Sakoda · Kaiser Foundation Research Institute · R01 · FY2023 · CA
Determinants and Outcomes of Nicotine Metabolite Ratio in HIV + Smokers
$536,730Robert Gross · University Of Pennsylvania · R01 · FY2021 · HL
Gefitinib-sensitive EGF receptor mutants in lung cancer
$536,728Jeffrey E Settleman · Massachusetts General Hospital · R01 · FY2006 · CA
Genetic Determinants of Tumor Growth and Drug Sensitivity in EGFR Mutant Lung Cancer
$536,716Katerina Abigail Politi · Yale University · R01 · FY2024 · CA
Genomics and Functional Characterization of NF1-mutated Lung Cancer
$536,682Eric Collisson · University Of California, San Francisco · R01 · FY2021 · CA